Google
SGHT — SIGHT SCIENCES INC (Healthcare >> Medical Devices)
SGHT FAQ
What is SGHT's ROE?
SIGHT SCIENCES INC reports a Return on Equity (ROE) of -69.11%.
What is SGHT's dividend yield?
SIGHT SCIENCES INC offers a dividend yield of 0.00%.
What is SGHT's Deepscope Quality Score?
Deepscope rates SGHT's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy SGHT?
Deepscope's AI Timing Score for SGHT is 28 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does SGHT belong to?
SIGHT SCIENCES INC is classified under the Healthcare >> Medical Devices sector on the NASDAQ exchange.
|
USD 4.45
Price
-0.15
(-3.26%)
Day Change
|
|
|---|
SGHT, ファンダメンタルスコアはnot good ( ファンダメンタル = 31) そして テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROAが低い
ROEの伸びが低い
平均ROEが低い
ROEが昨年度比で低い
ROAの伸びが低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...
| Deepscope 分析 |
|
42% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 98 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 4.45 |
| PBV / Sector |
4.64 / 7.50
|
| Earning Per Share | -0.66 |
| PE / Sector |
N/A / 29.01
|
| PEG or PE/Growth / Sector |
N/A / 0.39
|
| Average 1M Daily Value |
0.91 M
GREAT
|
| Average 1W Daily Value |
0.60 M
GREAT
|
| Timing Factors |
|
57% |
| Financial Health |
|
45% |
| ポイントになる統計 |
|
56% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-06-06 09:09:26 |
| Symbol | SGHT |
| Name | SIGHT SCIENCES INC |
| Sector | Healthcare >> Medical Devices |
| Market | NASDAQ |
| Listed Shares | 54.41 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 250.29 / 18,389.26 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 4040 Campbell Avenue, Menlo Park, CA, United States, 94025
Phone: 877 266 1144
Website: https://www.sightsciences.com
Employees: 186
Sector: Healthcare >> Medical Devices
Description: Sight Sciences, Inc., an ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases in the United States. The company operates in two segments, Surgical Glaucoma and Dry Eye. It offers OMNI, a surgical system family of products, such as OMNI Ergo for the catheterization and transluminal viscodilation of Schlemm's canal and cutting of the trabecular meshwork to reduce intraocular pressure in adult patients with open-angle glaucoma; and OMNI EDGE, an implant-free and minimally invasive glaucoma surgery technology. The company also provides SION, a bladeless and manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork; and TearCare system, a proprietary, interventional, dry eye device designed to melt and facilitate the comprehensive removal of meibomian gland obstructions and restore gland functionality and healthy oil production for adult patients with evaporative dry eye disease due to meibomian gland disease when used in conjunction with manual expression of the meibomian glands for ophthalmologists and optometrists. It serves hospitals, medical centers, and eyecare professionals through sales representatives and distributors. The company was incorporated in 2010 and is headquartered in Menlo Park, California.
ME vs SECTOR Healthcare >> Medical Devices
Click a bubble to view stock details · Bubble size represents market capitalization share
